Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM · BSE: 507789 · Pharmaceuticals & Biotechnology · 45 announcements

Share price: ₹236.58
Market cap: ₹1,560 Cr
Revenue (annual): ₹287.2 Cr
Net profit (annual): ₹43.08 Cr
P/E (TTM): 34.3×Sector 47.4×
Promoter holding: 69.05%+1.16% QoQ
FII holding: 2.30%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Employee Stock Options 4 Annual General Meeting 3 Earnings Call 2 Other Announcement 1 Merger & Restructuring 1 Management Change 1 Financial Results 1 Business Update 1 Board Meeting Date 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

17 Jul 2026 16:52 IST BSE

Merger & Restructuring

Jagsonpal Pharmaceuticals Merger & Restructuring

Jagsonpal Pharmaceuticals has completed the acquisition of an 85% equity stake in Aequitas Healthcare. This follows initial acquisition intimations made in June 2026.

Read the filing ↗